LLASHNEWSMedical aesthetics media & sourcingRequest Quote
Company NewsAesthetic DevicesConsumables

【India Delhi-】Lotus Herbals Leads INR 10 Crore Seed Round in India's First Korean Skin Clinic KorinMi

Source image preserved for article context.
Editor's note

This seed round, sourced from Lotus Herbals' leadership and KorinMi's founders, signals a strong buyer relevance for Korean aesthetic devices and consumables as the clinic chain plans to scale to 10 Indian metros, creating potential supply-chain opportunities for overseas suppliers.

Lotus Herbals, a major Indian beauty and wellness company, has led a INR 10 crore (approximately USD 1.2 million) seed round in KorinMi, India's first Korean skin clinic. The investment signals growing interest in Korean dermatological technology and premium clinical skincare among Indian consumers, a trend that overseas aesthetic device and consumable suppliers should monitor for potential distribution opportunities.

Investment details and board seat

KorinMi raised INR 10 crore in a seed funding round led by Lotus Herbals, with participation from strategic angel investors. As part of the deal, Lotus Herbals will join KorinMi's Board of Directors. The clinic chain was recently featured on Shark Tank India Season 5, gaining national visibility.

Growth and profitability track record

KorinMi launched its flagship clinic in Worldmark, Gurgaon, in 2025 after a successful INR 3 crore pre-seed round. Within six months of opening, the clinic served over 3,000 customers and achieved operational profitability. The brand reports a 50% customer repeat rate, indicating strong client retention and service demand.

Expansion plans and capital deployment

Untitled design

By May 2026, KorinMi will operate three clinics in the Delhi-NCR region, including new locations in South Delhi and Gurgaon. The fresh capital will fund national expansion to 10 clinics across major Indian metros over the next two to three years. This scaling plan creates potential demand for Korean-origin aesthetic devices, skincare consumables, and clinic fit-out solutions.

Strategic rationale from investors and founders

Nitin Passi, CMD of Lotus Herbals, stated: "KorinMi has uniquely positioned itself at the intersection of authentic Korean clinical expertise and the evolving needs of the Indian consumer. Their track record of early profitability and 50% repeat rate made them a natural fit for our portfolio." Co-founder Reshbha Munjal added: "Partnering with Lotus Herbals is a transformative step for KorinMi. Their deep understanding of the Indian beauty consumer, combined with our clinical approach, will allow us to scale our K-Beauty for India vision nationally." Jenovia Daun Jung, Co-founder and Korean Cosmetologist, noted: "Our goal has always been to bridge sophisticated Korean dermatological technology with the unique needs of Indian skin."

Sourcing context for overseas suppliers

KorinMi's rapid clinic expansion and focus on Korean dermatological technology suggest growing procurement needs for medical-grade aesthetic devices, injectables, and professional skincare products. Overseas manufacturers and distributors of Korean-origin equipment and consumables may find partnership opportunities as the chain scales beyond Delhi-NCR into other Indian metros.

Source: Read the original report | Published: June 08, 2026